KPRX — KIORA PHARMACEUTICALS INC
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2016-01-04.
Performance
Technicals
Others in Healthcare
Measured signals that fired on KPRX
| date | signal | measured base rate |
|---|---|---|
| 2026-06-17 | Short volume far above its own normal short | -0.76% over 21 days · t = -2.79 · n = 5,897 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-07-01 | Strem Brian M. President and CEO | Shares withheld for tax | 1.9K | 2.66 | 5.0K |
| 2026-07-01 | Tosca Melissa CFO | Shares withheld for tax | 911 | 2.66 | 2.4K |
| 2026-04-01 | Strem Brian M. President and CEO | Shares withheld for tax | 1.9K | 1.95 | 3.7K |
| 2026-04-01 | Daniels Eric Joseph Chief Development Officer | Shares withheld for tax | 929 | 1.95 | 1.8K |
| 2026-04-01 | Tosca Melissa CFO | Shares withheld for tax | 929 | 1.95 | 1.8K |
| 2026-03-06 | Tosca Melissa CFO | Grant or award | 6.5K | 0.00 | 0 |
| 2026-03-06 | Daniels Eric Joseph Chief Development Officer | Grant or award | 6.5K | 0.00 | 0 |
| 2026-03-06 | Strem Brian M. President and CEO | Grant or award | 16.7K | 0.00 | 0 |
| 2026-03-03 | Daniels Eric Joseph Chief Development Officer | Shares withheld for tax | 238 | 2.02 | 481 |
| 2026-03-03 | Strem Brian M. President and CEO | Shares withheld for tax | 238 | 2.02 | 481 |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| ADAR1 Capital Management, LLC | 324.1K | 167.9K |
| CITADEL ADVISORS LLC | 95.6K | 49.5K |
| GEODE CAPITAL MANAGEMENT, LLC | 92.3K | 47.9K |
| VANGUARD CAPITAL MANAGEMENT LLC | 38.3K | 19.9K |
| XTX Topco Ltd | 28.4K | 14.7K |
| VANGUARD FIDUCIARY TRUST CO | 25.1K | 13.0K |
| TWO SIGMA SECURITIES, LLC | 23.2K | 12.0K |
| Rangeley Capital, LLC | 19.3K | 10.0K |
| MORGAN STANLEY | 2.7K | 1.4K |
| UBS Group AG | 2.5K | 1.3K |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- Kiora Pharmaceuticals Inc (KPRX) filed form 8-K · 2026-08-19 · SEC EDGAR
Ask the AI about KPRX
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →